Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients

MLA

Linda Bussini, et al. “Neutralizing Monoclonal Antibodies for Early Treatment of Hospital‐acquired SARS‐CoV‐2 Infection in Hematologic Patients.” EJHaem, vol. 3, no. 4, Nov. 2022, pp. 1172–80. EBSCOhost, https://doi.org/10.1002/jha2.554.

APA

Linda Bussini, Diletta Testi, Beatrice Tazza, Chiara Oltolini, Sara Mastaglio, Chiara Sepulcri, Caterina Campoli, Filippo Trapani, Zeno Pasquini, Emanuela Zappulo, Matteo Bassetti, Pierluigi Viale, Malgorzata Mikulska, & Michele Bartoletti. (2022). Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients. EJHaem, 3(4), 1172–1180. https://doi.org/10.1002/jha2.554

Chicago

Linda Bussini, Diletta Testi, Beatrice Tazza, Chiara Oltolini, Sara Mastaglio, Chiara Sepulcri, Caterina Campoli, et al. 2022. “Neutralizing Monoclonal Antibodies for Early Treatment of Hospital‐acquired SARS‐CoV‐2 Infection in Hematologic Patients.” EJHaem 3 (4): 1172–80. doi:10.1002/jha2.554.